Health services research in cancer

Josep Maria Borras Andres

PRINCIPAL INVESTIGATORS
  • Julieta Corral Garcia
  • Joan Prades Pérez
  • Josepa Ribes Puig
  • Pilar Mur Molina
  • Ramón Clèries Soler
  • Rebeca Font Marimon
CLINICAL RESEARCHERS
  • Josep Alfons Espinas Piñol
  • Paula Manchón Walsh
  • Társila Ferro García
  • Josep Maria Escriba Jordana
  • Maite Antonio Rebollo
PREDOCTORAL RESEARCHERS
  • Darinka Ignacia Rivera Villalobos
SCIENTIFIC SUPPORT
  • Angels Melia Florit
  • Nuria Mila Diaz
  • Xavier Sanz Ayllon
  • Laura Guarga Sole
  • Jordi Galvez Escañuela
  • Laura Pareja Fernandez
  • Laura Esteban Etchamendi
  • Andreu Albiach De Miguel
  • Laura Roca Bielva
  • Judit Solà Munmany
MANAGEMENT SUPPORT
  • Meritxell Nomen Artal
  • Carme Prades Perez
Cancer
EPIBELL

Scientific production

13

PAPERS

Average IF: 4,08

7

LED PAPERS

Average IF: 4,79

2 PUBLICATIONS IN FIRST DECILE

5 PUBLICATIONS IN FIRST QUARTILE

12 PUBLICATIONS IN OPEN ACCESS

Selected publications

  • Prades,J;Kozhaeva,O;Otth,M;Kearns,P;Ladenstein,R;Rizzari,C;Heenen,D et al, Do national cancer control plans address care and research for children, adolescents, and young adults? A review of status, priorities, and recommendations across 41 European countries., Lancet Reg. Health-Eur., 2024;49101155-101155, doi:10.1016/j.lanepe.2024.101155
  • Vargas,I;Mogollón Pérez,AS;Eguiguren,P;Torres,AL;Peralta,A;Rubio Valera,M;Jervelund,SS et al, Understanding the health system drivers of delayed cancer diagnosis in public healthcare networks of Chile, Colombia and Ecuador: A qualitative study with health professionals, managers and policymakers., Soc Sci Med, 2024;365117499-117499, doi:10.1016/j.socscimed.2024.117499
  • Navarro Sabate,A;Font,R;Martínez Soler,F;Solà,J;Tortosa,A;Ribes,J;Benito Aracil,L et al, The Impact of the COVID-19 Pandemic on Adherence to Endocrine Therapy for Breast Cancer in Catalonia (Spain), Cancers2024;16(2):doi:10.3390/cancers16020426
  • Andrianova,MA;Seplyarskiy,VB;Terradas,M;Sanchez Heras,AB;Mur,P;Soto,JL;Aiza,G et al, Discovery of recessive effect of human polymerase d proofreading deficiency through mutational analysis of POLD1-mutated normal and cancer cells, Eur J Hum Genet, 2024;32(7):837-845, doi:10.1038/s41431-024-01598-8
  • Rivera,D;Prades,J;Borràs,JM;Aliste,L;Manchon Walsh,P, Multidisciplinary team meetings and their impact on survival in rectal cancer. Population-based analysis in Catalonia (Spain), Eur J Surg Oncol, 2024;50(12):108675-108675, doi:10.1016/j.ejso.2024.108675

Research highlights

PROJECTS

9 Ongoing competitive projects

1 Ongoing clinical trial

PUBLISHED WORKS

1 Clinical guideline
2 Theses

NETWORKS

AGAUR SGR GRC

Selected projects

  • 848294. 4-IN THE LUNG RUN: towards INdividually tailored INvitations, screening INtervals, and INtegrated co-morbidity reducing strategies in lung cancer screening. COMISSIÓ EUROPEA. Budget: 526.575€. 2020-2025. PI: ESPINAS PIÑOL, JOSEP ALFONS.
  • 101104777. ONCODIR – Evidence-based Participatory Decision Making for Cancer Prevention through implementation research. COMISSIÓ EUROPEA. Budget: 134.437,5€. 2023-2026. PI: Borràs Andrés, Josep Mª.
  • 101136953. DEFINITIVE: Diagnostic HER2DX-guided treatment for patients with early-stage HER2-positive breast cancer (101136953). COMISSIÓ EUROPEA. Budget: 126.708,75€. 2023-2028. PI: Borràs Andrés, Josep Mª.
  • 101096667. MELCAYA: Novel health care strategies for melanoma in children, adolescents and young adults. COMISSIÓ EUROPEA. Budget: 110.000€. 2022-2026. PI: Borràs Andrés, Josep Mª.PI21/00687. Evaluación de una estrategia de intervención para la mejora de la adherencia a la terapia endocrina en mujeres con cáncer de mama basada en datos del sistema sanitario en Cataluña. Instituto de Salud Carlos III (ISCIII). Budget: 99.861,3€. 2022-2026. PI: Borràs Andrés, Josep Mª.